During the past decade, Tohoku Medical And Pharmaceutical University Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tohoku Medical And Pharmaceutical University Hospital" #1 sponsor was "Janssen Pharmaceutical K.K." with 3 trials, followed by "Bayer" with 2 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "North East Japan Study Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tohoku Medical And Pharmaceutical University Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tohoku Medical And Pharmaceutical University Hospital" are "Anemia" (1 trials), "Atrial Fibrillation" (1 trials), "Dermatomyositis" (1 trials), "Extensive Disease Small Cell Lung Cancer" (1 trials) and "Idiopathic Interstitial Pneumonia" (1 trials). Many other conditions were trialed in "Tohoku Medical And Pharmaceutical University Hospital" in a lesser frequency.

Most popular intervention types in "Tohoku Medical And Pharmaceutical University Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Androgen-deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tohoku Medical And Pharmaceutical University Hospital" are 8 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Tohoku Medical And Pharmaceutical University Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tohoku Medical And Pharmaceutical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tohoku Medical And Pharmaceutical University Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".